secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jade Biosciences, Inc. (JBIO)
CIK:        0001798749
Form:       8-K
Filed at:   2025-04-21T23:59:59+00:00
Accession:  0001104659-25-036566
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.07, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aerovate stockholders approve merger with Jade Biosciences, 1-for-35 reverse split
--------------------------------------------------------------------------------

- All eight proposals approved at April 16 special meeting, including merger and reverse stock split.
- Board approves 1-for-35 reverse split, reducing outstanding from ~30M to ~0.8M shares.
- Special cash dividend of $69.6M ($2.40/share) unaffected; record date April 25.
- Combined company to trade as JBIO on Nasdaq starting April 29 after merger close.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1798749/000110465925036566/0001104659-25-036566-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1798749/000110465925036566/tm2512432d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-036566

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer